MK
Mamta Kumari
About Mamta Kumari
Data last updated:
Mamta Kumari has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Nikkon Lifescience Private Limited and Medimart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nikkon Lifescience Private Limited at ₹4.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nikkon Lifescience Private Limited U24302KA2018PTC115362 | Director | 09 Aug 2018 | 2018 | ₹4.01 Cr (FY 2025) | Active |
| Medimart Pharma Private Limited U51902BR2016PTC031833 | Director | 20 Jun 2016 | 2016 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mamta Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mamta Kumari
Mamta Kumari has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Nikkon Lifescience Private Limited and Medimart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nikkon Lifescience Private Limited at ₹4.01 Cr (FY 2025).
Mamta Kumari is associated with 2 companies as Director, including Nikkon Lifescience Private Limited (₹4.01 Cr), Medimart Pharma Private Limited.
Mamta Kumari has expertise in General Business.
Mamta Kumari has 10 years in corporate governance.
By reported revenue, the largest current company of Mamta Kumari is Nikkon Lifescience Private Limited, with revenue of ₹4.01 Cr (FY 2025).
Mamta Kumari currently holds positions at 2 companies: Nikkon Lifescience Private Limited (₹4.01 Cr), Medimart Pharma Private Limited.